These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7790735)

  • 21. Effect of i.v. glucose versus combined i.v. plus oral glucose on human tumour extracellular pH for potential sensitization to thermoradiotherapy.
    Leeper DB; Engin K; Wang JH; Cater JR; Li DJ
    Int J Hyperthermia; 1998; 14(3):257-69. PubMed ID: 9679706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia.
    Prescott DM; Charles HC; Sostman HD; Page RL; Thrall DE; Moore D; Oleson JR; Dewhirst MW
    Int J Hyperthermia; 1993; 9(5):745-54. PubMed ID: 8245584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human tumor extracellular pH as a function of blood glucose concentration.
    Leeper DB; Engin K; Thistlethwaite AJ; Hitchon HD; Dover JD; Li DJ; Tupchong L
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):935-43. PubMed ID: 8138447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo tumour extracellular pH monitoring using electron paramagnetic resonance: the effect of X-ray irradiation.
    Goodwin J; Yachi K; Nagane M; Yasui H; Miyake Y; Inanami O; Bobko AA; Khramtsov VV; Hirata H
    NMR Biomed; 2014 Apr; 27(4):453-8. PubMed ID: 24470192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH in human tumour xenografts: effect of intravenous administration of glucose.
    Volk T; Jähde E; Fortmeyer HP; Glüsenkamp KH; Rajewsky MF
    Br J Cancer; 1993 Sep; 68(3):492-500. PubMed ID: 8353039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes and consequences of tumour acidity and implications for treatment.
    Stubbs M; McSheehy PM; Griffiths JR; Bashford CL
    Mol Med Today; 2000 Jan; 6(1):15-9. PubMed ID: 10637570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion.
    Parkins CS; Stratford MR; Dennis MF; Stubbs M; Chaplin DJ
    Br J Cancer; 1997; 75(3):319-23. PubMed ID: 9020474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the unmodified initial tissue pH of human tumours and the response to combined radiotherapy and local hyperthermia treatment.
    van den Berg AP; Wike-Hooley JL; Broekmeyer-Reurink MP; van der Zee J; Reinhold HS
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):73-8. PubMed ID: 2920770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH and therapy of human cancers.
    Evelhoch JL
    Novartis Found Symp; 2001; 240():68-80; discussion 80-4, 152-3. PubMed ID: 11727937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH distributions in spontaneous and isotransplanted rat tumours.
    Kallinowski F; Vaupel P
    Br J Cancer; 1988 Sep; 58(3):314-21. PubMed ID: 3179183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling tumour acidity and invasion.
    Webb SD; Sherratt JA; Fish RG
    Novartis Found Symp; 2001; 240():169-81; discussion 181-5. PubMed ID: 11727928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human tumour pH and its variation.
    Wike-Hooley JL; van den Berg AP; van der Zee J; Reinhold HS
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):785-91. PubMed ID: 4043168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH distribution in human tumors.
    Thistlethwaite AJ; Leeper DB; Moylan DJ; Nerlinger RE
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1647-52. PubMed ID: 4030433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH studies in human malignant tumours.
    Ashby BS
    Lancet; 1966 Aug; 2(7458):312-5. PubMed ID: 4161494
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
    Gerweck LE; Seetharaman K
    Cancer Res; 1996 Mar; 56(6):1194-8. PubMed ID: 8640796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy.
    Wan X; Chen C; Zhan J; Ye S; Li R; Shen M
    Front Bioeng Biotechnol; 2024; 12():1415191. PubMed ID: 39148942
    [No Abstract]   [Full Text] [Related]  

  • 37. Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities.
    Deb R; Torres MDT; Boudný M; Koběrská M; Cappiello F; Popper M; Dvořáková Bendová K; Drabinová M; Hanáčková A; Jeannot K; Petřík M; Mangoni ML; Balíková Novotná G; Mráz M; de la Fuente-Nunez C; Vácha R
    J Med Chem; 2024 Aug; 67(16):14040-14061. PubMed ID: 39116273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing Dual-Responsive Drug Delivery Systems: The Role of Phase Change Materials and Metal-Organic Frameworks.
    Wei W; Lu P
    Materials (Basel); 2024 Jun; 17(13):. PubMed ID: 38998154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
    Dutta D; Ray P; De A; Ghosh A; Hazra RS; Ghosh P; Banerjee S; Diaz FJ; Upadhyay SP; Quadir M; Banerjee SK
    PLoS One; 2024; 19(4):e0297749. PubMed ID: 38687749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theranostic Fluorescent Probes.
    Sharma A; Verwilst P; Li M; Ma D; Singh N; Yoo J; Kim Y; Yang Y; Zhu JH; Huang H; Hu XL; He XP; Zeng L; James TD; Peng X; Sessler JL; Kim JS
    Chem Rev; 2024 Mar; 124(5):2699-2804. PubMed ID: 38422393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.